Bank Hapoalim BM’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,221
Closed -$264K 199
2021
Q4
$264K Sell
6,221
-886
-12% -$37.2K 0.03% 217
2021
Q3
$308K Hold
7,107
0.03% 204
2021
Q2
$304K Buy
+7,107
New +$299K 0.03% 210
2021
Q1
Sell
-5,627
Closed -$202K 233
2020
Q4
$202K Buy
+5,627
New +$203K 0.03% 198
2020
Q3
Sell
-7,689
Closed -$270K 180
2020
Q2
$270K Buy
+7,689
New +$277K 0.06% 158

Other funds holding BSX

Bank Hapoalim BM's BSX Position: Q1 2022 in Review

Bank Hapoalim BM sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 6,221 shares — an estimated $264K sold.

Bank Hapoalim BM first reported a position in BSX in Q2 2020 and held it in 5 quarters. The position peaked at $308K in Q3 2021. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Bank Hapoalim BM reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
  • Bank Hapoalim BM sold 6,221 Boston Scientific shares in Q1 2022, an estimated $264K.
  • Bank Hapoalim BM first reported a position in Boston Scientific in Q2 2020 and held it in 5 quarters.
  • Bank Hapoalim BM's Boston Scientific position peaked at $308K in Q3 2021.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Bank Hapoalim BM's 13F filing for Q1 2022, filed 28 Apr 2022.